Resources Contact Us Home
Modified factor VIII

Image Number 7 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
System and method for calibrating display device using transfer functions
Stable light source device
Flip-chip mounting resin composition and bump forming resin composition
Process for recovering and recycling an acid catalyst
Creating three dimensional graphics data
Device and method for generating soft tissue contrast images
Selection of system parameters based on non-acoustic sensor information
  Randomly Featured Patents
Process for making textured yarn
Four-wheel drive control system
Flexible cooler
Apparatus and method for determining the orientation of an object such as vehicle wheel alignment
System for determining the position of a knee prosthesis
Method and apparatus for video decoding to improve picture quality based on picture quality estimation, in the presence of noise
Telephone outlet with packet telephony adaptor, and a network using same
Circuit for accurately measuring phase relationship of BPSK signals
Remote control transmitter unit
Schnabel railway car skid shipping assembly